Abstract
This study was designed to determine whether four peptide hormones consisting of amino acids 1–30—long-acting natriuretic hormone (LANH), 31–67 (vessel dilator), 79–98 (kaliuretic hormone), and 99–126 (atrial natriuretic hormone [ANH])—of the 126 amino acid atrial natriuretic prohormone increase the circulating concentration of testosterone in healthy humans (n=30). Vessel dilator, kaliuretic hormone, LANH, and ANH increased the circulating concentration of testosterone 3.8, 2.6, 3.9, and 3.4-fold, respectively (p<0.01 for each), when infused at 100 ng/(kg of body wt·min) for 60 min. The increases in testosterone lasted 2.5–3 h after cessation of the respective atrial natriuretic peptides’ infusions. ANH, vessel dilator, LANH, and kaliuretic hormone increased luteinizing hormone (LH) 3-to 8.4-fold (p<0.001) during infusion, with the maximal increase in LH being 6.7- to 11.7-fold (p<0.001) secondary to these cardiac hormones. Vessel dilator and kaliuretic hormone increased LH before increasing testosterone in a sequential fashion. These data suggest that four peptide hormones—ANH, LANH, vessel dilator, and kaliuretic hormone—increase the circulating con-centrations of LH and testosterone in humans.
Similar content being viewed by others
References
Matsubara, H., Hirata, Y., Yoshimi, et al. (1987). Biochem. Biophys. Res. Commun. 145, 336–343.
Hong, M., Yan, Q., Tao, B., et al. (1992). Biol. Chem. Hoppe. Seyler 373, 213–218.
Vesely, D. L. (1992). Atrial natriuretic hormones. Prentice-Hall: Englewood Cliffs, NJ.
Bex, F. and Crobin, A. (1985). Eur. J. Pharmacol. 115, 125, 126.
Mukhopadhyay, A. K., Bohnet, H. G., and Leidenberger, F. A. (1986). FEBS Lett. 202, 111–116.
Pandey, K. N., Pavlou, S. N., Kovacs, W. J., and Inagami, T. (1986). Biochem. Biophys. Res. Commun. 138, 399–404.
Mukhopadhyay, A. K., Schumacher, M., and Leidenberger, F. A. (1986). Biochem. J. 239, 463–467.
Foresta, C., Mioni, R., and Caretto, A. (1987). Arch. Androl. 19, 253–259.
Foresta, C., Mioni, R., Miotto, D., DeCarlo, E., Facchin, F., and Varotto, A. (1991). J. Clin. Endocrinol. Metab. 72, 392–395.
Vesely, D. L., Norris, J. S., Walters, J. M., Jespersen, R. R., and Baeyens, D. A. (1987). Biochem. Biophys. Res. Commun. 148, 1540–1548.
Martin, D. R., Pevahouse, J. B., Trigg, D. J., Vesely, D. L., and Buerkert, J. E. (1990). Am. J. Physiol. 258, F1401-F1408.
Gunning, M. E., Brady, H. R., Otuechare, G., et al. (1992). J. Clin. Invest. 89, 1411–1417.
Vesely, D. L., Douglass, M. A., Dietz, J. R., et al. (1994). Circulation 90, 1129–1140.
Vesely, D. L., Douglass, M. A., Dietz, J. R., et al. (1994). J. Clin. Endocrinol. Metab. 78, 1128–1134.
Benjamin, B. A. and Peterson, T. V. (1995). Am. J. Physiol. 269, R1351-R1355.
Villarreal, D., Reams, G. P., Taraben, A., and Freeman, R. H. (1999). Proc. Soc. Exp. Biol. Med. 221, 166–170.
Vesely, D. L., Dietz, J. R., Parks, J. R., et al. (1998). Circulation 98, 323–329.
Dietz, J. R., Scott, D. Y., Landon, C. S., and Nazian, S. J. (2001). Am. J. Physiol. 280, R1510-R1517.
Winters, C. J., Sallman, A. L., Baker, B. J., Meadows, J., Rico, D. M., and Vesely, D. L. (1989). Circulation 80, 438–449.
Hunter, E. F. M., Kelly, P. A., Prowse, C., Woods, R. J., and Lowry, P.J. (1998). Scand. J. Clin. Lab. Invest. 58, 205–216.
Vesely, D. L., Norsk, P., Winters, C. J., Rico, D. M., Sallman, A. L., and Epstein, M. (1989). Proc. Soc. Exp. Biol. Med. 192, 230–235.
Baker, B. J., Wu, W. L., Winters, C. J., et al. (1991). Am. Heart J. 122, 1395–1402.
Gerbes, A. L., Arnedt, M., Ritter, D., Jungst, D., Zahringer, J., and Paumgartner, G. (1985). N. Engl. J. Med. 313, 1609,1610.
Vesely, D. L., Preston, R., Winters, C. J., Rico, D. M., Sallman, A. L., and Epstein, M. (1991). Am. J. Nephrol. 11, 207–216.
Winters, C. J., Sallman, A. L., Meadows, J., Rico, D. M., and Vesely, D. L. (1988). Biochem. Biophys. Res. Commun. 150, 231–236.
Winters, C. J. and Vesely, D. L. (1991). Nephron 58, 17–22.
Franz, M., Woloszczuk, W., and Horl, W. H. (2000). Kidney Int. 58, 374–383.
Melmed, S. and Braunstein, G. D. (1998). In: Internal medicine, 5th ed. Stein, J. H. (ed). Mosby: St. Louis, MO.
Schumacher, H., Muller, D., and Mukhopadhyay, A. K. (1992). Mol. Cell. Endocrinol. 90, 47–52.
Khurana, M. L. and Pandey, K. N. (1993). Endocrinology 133, 2141–2149.
Vesely, D. L. (1992). Mol. Cell. Biochem. 109, 43–50.
Foresta, C. and Mioni, R. (1988). Arch. Androl. 21, 181–187.
Horvath, J., Ertl, T., and Schally, A. V. (1986). Proc. Natl. Acad. Sci. USA 83, 3444–3446.
Samson, W. K., Aguila, M. C., and Bianchi, R. (1988). Endocrinology 122, 1573–1582.
Abou-Samra, A. B., Catt, K. J., and Aguilera, G. (1987). Endocrinology 120, 18–24.
Ackerman, B. H., Wyeth, R. P., Vesely, D. L., et al. (1992). J. Clin. Pharmacol. 32, 415–421.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Vesely, D.L., San Miguel, G.I., Hassan, I. et al. Four cardiac hormones increase circulating concentrations of luteinizing hormone and testosterone. Endocr 17, 145–150 (2002). https://doi.org/10.1385/ENDO:17:2:145
Received:
Revised:
Accepted:
Issue Date:
DOI: https://doi.org/10.1385/ENDO:17:2:145